News Detail
Mumbai, 17 Nov 2020: The Drugs Controller General of India (DCGI) has directed the state licensing authorities (SLAs) to direct manufacturers to suspend the manufacturing, sale or distribution of ulipristal acetate tablets 5 mg based on the recommendation of European Medicines Ag......
View Details
Source : Pharmabiz
Related News
- Maha FDA writes to Central govt asking it to cap Remdesivir rate (08-03-2021)
- Bhubaneswar gets common facility center for Pharmaceutical Cluster (08-03-2021)
- Sub-committee on FDCs to hear stakeholders from April 19 (08-03-2021)
- DCGI urged to not accept data from "discredited test" for depression drugs (08-03-2021)
- US FDA warns against one-dose regimen for coronavirus vaccines (07-03-2021)
- Patient given fake corona injection died: Gujarat Govt (07-03-2021)
- Quicker decrease in Covid infection treated with Molnupiravir (07-03-2021)
- SII writes to PMO to allow manufacturing, stockpiling of non-COVID vaccines during trial (07-03-2021)
- PM Modi's photo from Covid vaccine certificates must be removed: EC to Centre (07-03-2021)
- Covid survivors may suffer cognitive complications (06-03-2021)